Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
DAPA-CKD Trial Committees and Investigators, David C Wheeler*, Bergur V Stefánsson, Niels Jongs, Glenn M Chertow, Tom Greene, Fan Fan Hou, John J V McMurray, Ricardo Correa-Rotter, Peter Rossing, Robert D Toto, C David Sjöström, Anna Maria Langkilde, Hiddo J L Heerspink
Research output: Contribution to journal › Article › Academic › peer-review
383Citations
(Scopus)
3141Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial'. Together they form a unique fingerprint.